An AI Agent Injected Drugs Into a Live Mouse’s Brain
| Source: Wired AI
Tags: Exin Therapeutics, Gabriel Ocana Santero, Claude Opus, lab automation, gene therapy
Exin Therapeutics let an AI agent pick a gene therapy and control a robotic rig to inject it into a live epileptic mouse's brain, an early test of agents operating lab equipment directly.
Details
Exin Therapeutics CEO Gabriel Ocana Santero connected an AI agent to a custom surgical setup with a motorized restraint, a camera and an injector. After a veterinary surgeon performed the craniotomy, the agent chose a treatment from 19 options in a spreadsheet, selected the brain region and coordinates, and controlled the robotic arm, needle, volume and speed. The team was testing a gene therapy meant to reduce seizures in an epileptic mouse, and initially used Anthropic's Claude Opus. Santero argues agents need direct lab access because models trained on literature miss failed experiments and real-time decisions. It is a single demonstration announced on social media, not a peer-reviewed study.